Increased Serum Level of Vascular Endothelial Growth Factor in Pulmonary Tuberculosis CDC Daily UpdateImportant note: Information in this article was accurate in 2000. The state of the art may have changed since the publication date.
Click here to return to CDC Daily Update main menu
DonateNow
Print this article

Increased Serum Level of Vascular Endothelial Growth Factor in Pulmonary Tuberculosis

American Journal of Respiratory and Critical Care Medicine Online (www.ajrccm.atsjournals.org) (09/00) Vol. 162, No. 3, P. 1120
Matsuyama, Wataru; Hashiguchi, Teruto; Matsumuro, Kenji; et al.


Japanese researchers investigated an increased serum level of vascular endothelial growth factor (VEGF) among patients with Crohn's disease. The scientists believed that VEGF could be related to pulmonary tuberculosis (TB), so they analyzed the serum level of 43 patients with active TB, 29 patients with old TB, and 25 with acute bronchitis. The serum levels were higher in patients with active TB than those in the other groups. The researchers conclude that VEGF could be associated with the pathogenesis of pulmonary TB.
001010
AD001816

Copyright © 2000 - Information, Inc., Bethesda, MD. The CDC National Center for HIV, STD and TB Prevention provides the following information as a public service only. Providing synopses of key scientific articles and lay media reports on HIV/AIDS, other sexually transmitted diseases and tuberculosis does not constitute CDC endorsement. This daily update also includes information from CDC and other government agencies, such as background on Morbidity and Mortality Weekly Report (MMWR) articles, fact sheets, press releases and announcements. Reproduction of this text is encouraged; however, copies may not be sold, and the CDC HIV/STD/TB Prevention News Update should be cited as the source of the information. Contact the sources of the articles abstracted below for full texts of the articles.

AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Elton John AIDS Foundation, iMetrikus, Inc., John M. Lloyd Foundation, the National Library of Medicine, and donations from users like you. Always watch for outdated information. This article first appeared in 2000. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 2000. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .